Viking Therapeutics
VKTX
#3666
Rank
NZ$4.53 B
Marketcap
$40.42
Share price
-6.61%
Change (1 day)
-66.94%
Change (1 year)

Earnings for Viking Therapeutics (VKTX)

Earnings in 2024 (TTM): -NZ$0.19 Billion

According to Viking Therapeutics 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -NZ$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viking Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$0.2 Billion28.02%
2023 -NZ$0.16 Billion24.73%
2022 -NZ$0.13 Billion25.24%
2021 -NZ$98.26 Million39.23%
2020 -NZ$70.57 Million53.21%
2019 -NZ$46.06 Million16.84%
2018 -NZ$39.42 Million7.22%
2017 -NZ$36.77 Million39.68%
2016 -NZ$26.33 Million-37.05%
2015 -NZ$41.82 Million6.94%
2014 -NZ$39.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.91 Billion 358.83%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.72 M-103.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$11.27 Million-94.27%๐Ÿ‡บ๐Ÿ‡ธ USA